Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Trogarzo out in Europe

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Apr 27, 2022 9:51am

89 Views

Post# 34635224

RE:RE:RE:RE:Trogarzo out in Europe

I just think it has to be the case that everything is fine and dandy until it isn't. This is about contracts, the contract is in place until it's decided to terminate the contract, I can't see a company ever saying we are thinking about ending a contract. It's in place then the decision to terminate is enacted, there is no public statement about the process between those two states.

What you really want them to say is "hint, hint, we are thinking of quitting Europe". That's never going to happen. There's no real reason to lose faith with management because they did what is normal procedure.

palinc2000 wrote:

I am not against the decision but even Paul 's vomments on Trog in Europe exactly 2 weeks ago on April 13 did not hint at capitulation....He could have said then that they were re evaluating the path forward
So for me it is all about transparency and trust
Both moving a notch down

SPCEO1 wrote: I mentioned the possibility of shutting down Europe as a result of what I heard them say about rejecting Germany's pricing and the tiny sales. But I also said that having just paid Taimed a $5 million milestone payment last Fall, they might try to make it work. I guess they were on the hook for payment regardless so that really didn't factor into the equation. Europe has not been kind to TH. First Egrifta got shot down there and now this. While unfortunate, this was the right move to make. Perhaps it could have been made earlier but I suppose there was always a chance pricing might have been better. This is another piece of evidence that highlights that while companies may tell the truth they don't tell the whole truth. TH spoke optimistically about pricing in Europe not that long ago. They likely had reasons to do so based on partial info but had they shared all the info, we might have drawn a different conclusion.

palinc2000 wrote: The Feb 24 2022 CC with regards to the status of Trog in Europe did not in my opinion in any way prepare us to declaring defeat 2 months down the road........